about
Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network ModelA head and neck cancer tumor response-specific gene signature for cisplatin, 5-fluorouracil induction chemotherapy fails with added taxanesClaudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancerDrugging PI3K in cancer: refining targets and therapeutic strategiesPersonalized medicine in neuro-oncology.
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Personalized medicine: patient-predictive panel power.
@en
Personalized medicine: patient-predictive panel power.
@nl
type
label
Personalized medicine: patient-predictive panel power.
@en
Personalized medicine: patient-predictive panel power.
@nl
prefLabel
Personalized medicine: patient-predictive panel power.
@en
Personalized medicine: patient-predictive panel power.
@nl
P50
P1433
P1476
Personalized medicine: patient-predictive panel power.
@en
P304
P356
10.1016/J.CCR.2012.03.030
P577
2012-04-01T00:00:00Z